Late Breaking Abstract - Cradle-to-grave emission reduction for dry powder inhaler product portfolio

How much can we afford? The balance of costs and clinical benefits in the light of chronic respiratory diseases

Chair(s): Stylianos Loukides, Sylvia Hartl

Session type: Poster session

Satu Lahelma

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Development, validation and application of an asthma cost-effectiveness model for value assessment of digital inhaler adherence enhancing strategies

Susanne J. Van De Hei

Poster

Abstract

Cost effectiveness analysis of treatments for children with uncontrolled asthma symptoms despite taking inhaled corticosteroids

Giovanna Culeddu

Poster

Abstract

Feelings of Family Members of Patients with Chronic Respiratory Disease Before and After the Introduction of Home Oxygen Therapy

Rika Tonami

Abstract

ANALYSIS OF THE CLINICAL CHARACTERISTICS AND COMORBIDITIES OF PATIENTS WITH COPD AND HOME MECHANICAL VENTILATION

Adriana Martin Pascual

Poster

Abstract

Estimating costs associated with paediatric Respiratory Syncytial Virus infection managed in the hospital setting in England.

Rebecca Butfield

Poster

Abstract

A cost and environmental analysis of a vibrating mesh nebuliser

Amy Dymond

Poster

Abstract

Direct health care cost of Chronic Obstructive Pulmonary Disease (COPD) in Morocco:a cost of illness study.

Soumaya Benmaamar

Abstract

Health, environmental, and societal impact of asthma care pathway in the UK: A cost-of-illness study

Martina Orlovic

Poster

Abstract

The last hours in a pulmonology ward: a retrospective look at end-of-life care

Joana Da Silva Cruz Gameiro Duarte

Poster

Abstract

Evaluation of an audio-visual informed consent procedure in a diagnostic tuberculosis trial

Luis Gomez Paciello

Poster

Abstract

Late Breaking Abstract - Cradle-to-grave emission reduction for dry powder inhaler product portfolio

Satu Lahelma

Poster

Abstract

The ERS International Congress 2023, Milan

#{title}